Wolverine Trading’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $3.86M | Buy |
+50,000
| New | +$3.91M | ﹤0.01% | 1605 |
|
|
2025
Q2 | – | Sell |
-49,600
| Closed | -$3.52M | – | 4982 |
|
|
2025
Q1 | $3.52M | Sell |
49,600
-70,900
| -59% | -$5.07M | ﹤0.01% | 1222 |
|
|
2024
Q4 | $8.95M | Buy |
120,500
+21,300
| +21% | +$1.49M | 0.01% | 844 |
|
|
2024
Q3 | $6.6M | Buy |
99,200
+45,600
| +85% | +$3.31M | 0.01% | 886 |
|
|
2024
Q2 | $4.95M | Sell |
53,600
-50,200
| -48% | -$4.45M | 0.01% | 996 |
|
|
2024
Q1 | $9.92M | Buy |
103,800
+65,800
| +173% | +$5.53M | 0.01% | 663 |
|
|
2023
Q4 | $2.9M | Sell |
38,000
-19,900
| -34% | -$1.38M | ﹤0.01% | 1430 |
|
|
2023
Q3 | $4.01M | Buy |
57,900
+44,900
| +345% | +$3.61M | ﹤0.01% | 1126 |
|
|
2023
Q2 | $1.2M | Sell |
13,000
-25,400
| -66% | -$2.21M | ﹤0.01% | 1877 |
|
|
2023
Q1 | $3.13M | Sell |
38,400
-26,400
| -41% | -$2.08M | ﹤0.01% | 1099 |
|
|
2022
Q4 | $4.83M | Buy |
64,800
+32,700
| +102% | +$2.52M | 0.01% | 918 |
|
|
2022
Q3 | $2.69M | Buy |
32,100
+13,800
| +75% | +$1.33M | ﹤0.01% | 1201 |
|
|
2022
Q2 | $1.76M | Sell |
18,300
-4,500
| -20% | -$466K | ﹤0.01% | 1483 |
|
|
2022
Q1 | $2.67M | Buy |
+22,800
| New | +$2.56M | ﹤0.01% | 1508 |
|
|
2021
Q4 | – | Sell |
-36,200
| Closed | -$4.11M | – | 6150 |
|
|
2021
Q3 | $4.11M | Buy |
+36,200
| New | +$4.13M | ﹤0.01% | 1460 |
|
|
2021
Q2 | – | Sell |
-16,700
| Closed | -$1.38M | – | 6201 |
|
|
2021
Q1 | $1.38M | Buy |
+16,700
| New | +$1.41M | ﹤0.01% | 2334 |
|
|
2020
Q4 | – | Sell |
-33,100
| Closed | -$2.59M | – | 4969 |
|
|
2020
Q3 | $2.59M | Buy |
+33,100
| New | +$2.58M | 0.01% | 1282 |
|
|
2020
Q2 | – | Sell |
-73,200
| Closed | -$4.78M | – | 4738 |
|
|
2020
Q1 | $4.78M | Buy |
73,200
+12,000
| +20% | +$865K | 0.01% | 792 |
|
|
2019
Q4 | $4.74M | Buy |
61,200
+27,600
| +82% | +$2.16M | 0.01% | 1135 |
|
|
2019
Q3 | $2.43M | Buy |
+33,600
| New | +$2.36M | 0.01% | 1305 |
|
|
2019
Q2 | – | Sell |
-193,200
| Closed | -$12.3M | – | 4601 |
|
|
2019
Q1 | $12.3M | Buy |
193,200
+81,000
| +72% | +$4.62M | 0.04% | 426 |
|
|
2018
Q4 | $5.63M | Buy |
112,200
+11,700
| +12% | +$592K | 0.02% | 737 |
|
|
2018
Q3 | $5.83M | Buy |
100,500
+42,300
| +73% | +$2.07M | 0.01% | 868 |
|
|
2018
Q2 | $2.71M | Hold |
58,200
| – | – | 0.01% | 1331 |
|
|
2018
Q1 | $2.71M | Buy |
+58,200
| New | +$2.53M | 0.01% | 1331 |
|
|
2017
Q3 | – | Sell |
-58,500
| Closed | -$2.29M | – | 4574 |
|
|
2017
Q2 | $2.29M | Sell |
58,500
-57,900
| -50% | -$2.11M | 0.01% | 1157 |
|
|
2017
Q1 | $3.64M | Sell |
116,400
-17,100
| -13% | -$535K | 0.02% | 822 |
|
|
2016
Q4 | $4.17M | Buy |
+133,500
| New | +$4.33M | 0.02% | 841 |
|
Other funds holding EW
Wolverine Trading's EW Position: Q4 2024 in Review
Wolverine Trading sold out of Edwards Lifesciences (EW) in Q4 2024, closing a stake of 26,266 shares — an estimated $1.84M sold.
Wolverine Trading first reported a position in EW in Q4 2016 and held it in 15 quarters. The position peaked at $3.74M in Q4 2019. 1,226 funds tracked by Wall St. Rank hold EW as of Q4 2024.
- Wolverine Trading reported no remaining Edwards Lifesciences position as of Q4 2024 after selling out during the quarter.
- Wolverine Trading sold 26,266 Edwards Lifesciences shares in Q4 2024, an estimated $1.84M.
- Wolverine Trading first reported a position in Edwards Lifesciences in Q4 2016 and held it in 15 quarters.
- Wolverine Trading's Edwards Lifesciences position peaked at $3.74M in Q4 2019.
- 1,226 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q4 2024.
Based on Wolverine Trading's 13F filing for Q4 2024, filed 14 Feb 2025.